T cells with high BCL-2 expression induced by venetoclax impact anti-leukemic immunity "graft-versus-leukemia effects".
Nagasaki J, Nishimoto M, Koh H, Okamura H, Nakamae M, Sakatoku K, Ido K, Kuno M, Makuuchi Y, Takakuwa T, Nakashima Y, Hino M, Nakamae H.
Nagasaki J, et al. Among authors: okamura h.
Blood Cancer J. 2024 May 14;14(1):79. doi: 10.1038/s41408-024-01064-0.
Blood Cancer J. 2024.
PMID: 38744860
Free PMC article.
No abstract available.